The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer
Open accessAbstract
The post-transcriptional control of gene expression mediated by RNA-binding proteins (RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is essential to determine tumor cell fate and thus is a major determinant in cancerogenesis. The IGF2 mRNA binding protein family (IGF2BPs) comprises three RBPs. Two members of the family, IGF2BP1 and IGF2BP3, are bona fide oncofetal proteins, which are de novo synthesized in various human cancers. In vitro studies revealed that IGF2BPs serve as post-transcriptional fine-tuners modulating the expression of genes implicated in the control of tumor cell proliferation, survival, chemo-resistance and metastasis. Consistently, the expression of both IGF2BP family members was reported to correlate with an overall poor prognosis and metastasis in various human cancers. Due to the fact that most reports used a pan-IGF2BP antibody for studying IGF2BP expression in cancer, paralogue-specific functions can barely be evaluated at present. Nonetheless, the accordance of IGF2BPs' role in promoting an aggressive phenotype of tumor-derived cells in vitro and their upregulated expression in aggressive malignancies provides strong evidence that IGF2BPs are powerful post-transcriptional oncogenes enhancing tumor growth, drug-resistance and metastasis. This suggests IGF2BPs as powerful biomarkers and candidate targets for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
Kumar, M. S., Armenteros-Monterroso, E., East, P., Chakravorty, P., Matthews, N., Winslow, M. M., & Downward, J. (2014) · Nature · doi:10.1038/nature12785 · Cited by 253
RetractedReciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells
Chen, C.-L., Tsukamoto, H., Liu, J.-C., Kashiwabara, C., Feldman, D., Sher, L., Dooley, S., French, S. W., Mishra, L., Petrovic, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65859 · Cited by 162
RetractedTranscriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP
Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., Rothballer, A., Ascano, M., Jungkamp, A.-C., Munschauer, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.009 · Cited by 2,873
Bell, J. L., Wächter, K., Mühleck, B., Pazaitis, N., Köhn, M., Lederer, M., & Hüttelmaier, S. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1186-z · Cited by 783
Self-citationNielsen, J., Christiansen, J., Lykke-Andersen, J., Johnsen, A. H., Wewer, U. M., & Nielsen, F. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1262 · Cited by 721
Spatial regulation of β-actin translation by Src-dependent phosphorylation of ZBP1
Hüttelmaier, S., Zenklusen, D., Lederer, M., Dictenberg, J., Lorenz, M., Meng, X., Bassell, G. J., Condeelis, J., & Singer, R. H. (2005) · Nature · doi:10.1038/nature04115 · Cited by 647
Self-citationCharacterization of a β-Actin mRNA Zipcode-Binding Protein
Ross, A. F., Oleynikov, Y., Kislauskis, E. H., Taneja, K. L., & Singer, R. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2158 · Cited by 561
Asymmetrical β-actin mRNA translation in growth cones mediates attractive turning to netrin-1
Leung, K.-M., van Horck, F. P., Lin, A. C., Allison, R., Standart, N., & Holt, C. E. (2006) · Nature Neuroscience · doi:10.1038/nn1775 · Cited by 478
Yao, J., Sasaki, Y., Wen, Z., Bassell, G. J., & Zheng, J. Q. (2006) · Nature Neuroscience · doi:10.1038/nn1773 · Cited by 344
RNA‐binding IMPs promote cell adhesion and invadopodia formation
Vikesaa, J., Hansen, T. V., Jønson, L., Borup, R., Wewer, U. M., Christiansen, J., & Nielsen, F. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601039 · Cited by 341
Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs
Weidensdorfer, D., Stöhr, N., Baude, A., Lederer, M., Köhn, M., Schierhorn, A., Buchmeier, S., Wahle, E., & Hüttelmaier, S. (2009) · RNA · doi:10.1261/rna.1175909 · Cited by 318
Self-citationBernstein, P. L., Herrick, D. J., Prokipcak, R. D., & Ross, J. (1992) · Genes & Development · doi:10.1101/gad.6.4.642 · Cited by 297
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein
Müeller-Pillasch, F., Lacher, U., Wallrapp, C., Micha, A., Zimmerhackl, F., Hameister, H., Varga, G., Friess, H., Büchler, M., Beger, H. G., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201110 · Cited by 284
Integrative Genome Comparison of Primary and Metastatic Melanomas
Kabbarah, O., Nogueira, C., Feng, B., Nazarian, R. M., Bosenberg, M., Wu, M., Scott, K. L., Kwong, L. N., Xiao, Y., Cordon-Cardo, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010770 · Cited by 261
Jiang, Z., Chu, P. G., Woda, B. A., Rock, K. L., Liu, Q., Hsieh, C.-C., Li, C., Chen, W., Duan, H. O., McDougal, S., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70732-x · Cited by 242
Molecular Composition of IMP1 Ribonucleoprotein Granules
J⊘nson, L., Vikesaa, J., Krogh, A., Nielsen, L. K., Hansen, T. V., Borup, R., Johnsen, A. H., Christiansen, J., & Nielsen, F. C. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600346-mcp200 · Cited by 238
Real-Time Visualization of ZBP1 Association with β-Actin mRNA during Transcription and Localization
Oleynikov, Y., & Singer, R. H. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00044-7 · Cited by 226
Ostareck-Lederer, A., Ostareck, D. H., Cans, C., Neubauer, G., Bomsztyk, K., Superti-Furga, G., & Hentze, M. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4535-4543.2002 · Cited by 222
Liao, B., Hu, Y., Herrick, D. J., & Brewer, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500270200 · Cited by 211
mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry
Dai, N., Rapley, J., Angel, M., Yanik, M. F., Blower, M. D., & Avruch, J. (2011) · Genes & Development · doi:10.1101/gad.2042311 · Cited by 208
ZBP1 recognition of β-actin zipcode induces RNA looping
Chao, J. A., Patskovsky, Y., Patel, V., Levy, M., Almo, S. C., & Singer, R. H. (2010) · Genes & Development · doi:10.1101/gad.1862910 · Cited by 204
Zhang, J.-Y., Chan, E. K. L., Peng, X.-X., & Tan, E. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1101 · Cited by 202
Gutschner, T., Hämmerle, M., Pazaitis, N., Bley, N., Fiskin, E., Uckelmann, H., Heim, A., Groβ, M., Hofmann, N., Geffers, R., et al. (2014) · Hepatology · doi:10.1002/hep.26997 · Cited by 193
Self-citationCRD-BP Protects the Coding Region of βTrCP1 mRNA from miR-183-Mediated Degradation
Elcheva, I., Goswami, S., Noubissi, F. K., & Spiegelman, V. S. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.007 · Cited by 192
Asioli, S., Erickson, L. A., Righi, A., Jin, L., Volante, M., Jenkins, S., Papotti, M., Bussolati, G., & Lloyd, R. V. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.117 · Cited by 188
Phosphorylation of human Argonaute proteins affects small RNA binding
Rüdel, S., Wang, Y., Lenobel, R., Körner, R., Hsiao, H.-H., Urlaub, H., Patel, D., & Meister, G. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1032 · Cited by 188
The Platelet Aggregation-Inducing Factor Aggrus/Podoplanin Promotes Pulmonary Metastasis
Kunita, A., Kashima, T. G., Morishita, Y., Fukayama, M., Kato, Y., Tsuruo, T., & Fujita, N. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060790 · Cited by 182
IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes
Christiansen, J., Kolte, A. M., Hansen, T. V. O., & Nielsen, F. C. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0016 · Cited by 182
Jeng, Y., Chang, C., Hu, F., Chou, H. E., Kao, H., Wang, T., & Hsu, H. (2008) · Hepatology · doi:10.1002/hep.22459 · Cited by 179
The Oncofetal Protein IMP3: A Novel Biomarker for Endometrial Serous Carcinoma
Zheng, W., Yi, X., Fadare, O., Liang, S. X., Martel, M., Schwartz, P. E., & Jiang, Z. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181483ff8 · Cited by 166
Spatial arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control
Patel, V. L., Mitra, S., Harris, R., Buxbaum, A. R., Lionnet, T., Brenowitz, M., Girvin, M., Levy, M., Almo, S. C., Singer, R. H., et al. (2012) · Genes & Development · doi:10.1101/gad.177428.111 · Cited by 166
IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling
Stöhr, N., Köhn, M., Lederer, M., Glaß, M., Reinke, C., Singer, R. H., & Hüttelmaier, S. (2012) · Genes & Development · doi:10.1101/gad.177642.111 · Cited by 164
Self-citationYantiss, R. K., Woda, B. A., Fanger, G. R., Kalos, M., Whalen, G. F., Tada, H., Andersen, D. K., Rock, K. L., & Dresser, K. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000149688.98333.54 · Cited by 163
Suvasini, R., Shruti, B., Thota, B., Shinde, S. V., Friedmann-Morvinski, D., Nawaz, Z., Prasanna, K. V., Thennarasu, K., Hegde, A. S., Arivazhagan, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178012 · Cited by 158
Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer
Hammer, N. A., Hansen, T. V. O., Byskov, A. G., Meyts, E. R.-D., Grøndahl, M. L., Bredkjær, H. E., Wewer, U. M., Christiansen, J., & Nielsen, F. C. (2005) · Reproduction · doi:10.1530/rep.1.00664 · Cited by 148
Wächter, K., Köhn, M., Stöhr, N., & Hüttelmaier, S. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0111 · Cited by 147
Self-citationNielsen, J., Kristensen, M. A., Willemoës, M., Nielsen, F. C., & Christiansen, J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh754 · Cited by 140
Köbel, M., Xu, H., Bourne, P. A., Spaulding, B. O., Shih, I., Mao, T., Soslow, R. A., Ewanowich, C. A., Kalloger, S. E., Mehl, E., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.206 · Cited by 132
Schaeffer, D. F., Owen, D. R., Lim, H. J., Buczkowski, A. K., Chung, S. W., Scudamore, C. H., Huntsman, D. D., Ng, S. S. W., & Owen, D. A. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-59 · Cited by 124
Hoffmann, N. E., Sheinin, Y. M., Lohse, C. M., Parker, A. S., Leibovich, B. C., Jiang, Z., & Kwon, E. D. (2008) · Cancer · doi:10.1002/cncr.23296 · Cited by 122
Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma
Köbel, M., Weidensdorfer, D., Reinke, C., Lederer, M., Schmitt, W., Zeng, K., Thomssen, C., Hauptmann, S., & Hüttelmaier, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210563 · Cited by 121
Self-citationIMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development
Jønson, L., Christiansen, J., Hansen, T. V. O., Vikeså, J., Yamamoto, Y., & Nielsen, F. C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.015 · Cited by 114
Mammary Tumor Induction in Transgenic Mice Expressing an RNA-Binding Protein
Tessier, C. R., Doyle, G. A. R., Clark, B. A., Pitot, H. C., & Ross, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2927 · Cited by 110
IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis
Li, D., Yan, D., Tang, H., Zhou, C., Fan, J., Li, S., Wang, X., Xia, J., Huang, F., Qiu, G., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0648-5 · Cited by 109
Walter, O., Prasad, M. L., Lu, S., Quinlan, R., Edmiston, K. L., & Khan, A. A. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.05.005 · Cited by 109
Samanta, S., Sharma, V. M., Khan, A. A., & Mercurio, A. M. (2012) · Oncogene · doi:10.1038/onc.2011.620 · Cited by 104
Dai, N., Christiansen, J., Nielsen, F. C., & Avruch, J. (2013) · Genes & Development · doi:10.1101/gad.209130.112 · Cited by 99
Samanta, S., Pursell, B. M., & Mercurio, A. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.442319 · Cited by 92
Lochhead, P. J., Imamura, Y., Morikawa, T., Kuchiba, A., Yamauchi, M., Liao, X., Qian, Z. R., Nishihara, R., Wu, K., Meyerhardt, J. A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.021 · Cited by 91
IMP-3 is a novel progression marker in malignant melanoma
Pryor, J. G., Bourne, P. A., Yang, Q., Spaulding, B. O., SCOTT, G. A., & Xu, H. (2008) · Modern Pathology · doi:10.1038/modpathol.3801016 · Cited by 83
Jiang, Z., Lohse, C. M., Chu, P. G., Wu, C., Woda, B. A., Rock, K. L., & Kwon, E. D. (2008) · Cancer · doi:10.1002/cncr.23484 · Cited by 82
Jiang, Z., Chu, P. G., Woda, B. A., Liu, Q., Balaji, K. C., Rock, K. L., & Wu, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0504 · Cited by 79
The use of insulin like-growth factor II messenger RNA binding protein–3 in diagnostic pathology
Findeis-Hosey, J. J., & Xu, H. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.06.003 · Cited by 78
Levy, M., Lin, F., Xu, H., Dhall, D., Spaulding, B. O., & Wang, H. L. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.01.014 · Cited by 76
Zirkel, A., Lederer, M., Stöhr, N., Pazaitis, N., & Hüttelmaier, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt410 · Cited by 76
Self-citationWon, J., Gao, D., Chow, C., Cheng, J., Lau, S., Ellis, M. J., Perou, C. M., Bernard, P. S., & Nielsen, T. O. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.97 · Cited by 72
Li, C., Zota, V. E., Woda, B. A., Rock, K. L., Fraire, A. E., Jiang, Z., Lü, D., Xu, B., Dresser, K., Lutman, C. V., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800960 · Cited by 72
Role of IGF2BP3 in trophoblast cell invasion and migration
Li, W., Liu, D., Chang, W., Lu, X., Wang, Y., Wang, H., Zhu, C., Lin, H.-Y., Zhang, Y., Zhou, J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.545 · Cited by 67
Vargas, T. R., Boudoukha, S., Simon, A., Souidi, M., Cuvellier, S., Pinna, G., & Polesskaya, A. (2013) · Oncogene · doi:10.1038/onc.2013.252 · Cited by 60
Liao, B., Hu, Y., & Brewer, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.263913 · Cited by 57
Mhawech-Fauceglia, P. Y., Li, Y., Liu, S., & Pejovic, T. B. (2013) · Histopathology · doi:10.1111/his.12096 · Cited by 55
Wagner, M., Kunsch, S., Duerschmied, D., Beil, M., Adler, G., Mueller, F., & Gress, T. M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00402-5 · Cited by 52
IGF2BP1: A post-transcriptional “driver” of tumor cell migration
Stöhr, N., & Hüttelmaier, S. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20628 · Cited by 50
Self-citationIMP3 Distinguishes Uterine Serous Carcinoma From Endometrial Endometrioid Adenocarcinoma
Mhawech-Fauceglia, P. Y., Herrmann, F. R., Rai, H., Tchabo, N. E., Lele, S., Izevbaye, I., Odunsi, K. O., & Cheney, R. T. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcpqdqxj4fnrfqb · Cited by 48
IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma
Hu, S., Wu, X., Zhou, B., Xu, Z., Qin, J., Hao, L., Lv, L., Gao, Y., Deng, L., Yin, J., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1639-x · Cited by 44
Li, S., Cha, J., Kim, J., Kim, K., Kim, H. J., Nam, W., & Cha, I. (2010) · Head & Neck · doi:10.1002/hed.21457 · Cited by 43
Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors
Li, L., Xu, H., Spaulding, B. O., Liang Cheng, C., Simon, R. A., Yao, J. L., di Sant'Agnese, P. A., Bourne, P. A., & Huang, J. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.12.012 · Cited by 39
Wachter, D. L., Kristiansen, G., Soll, C., Hellerbrand, C., Breuhahn, K., Fritzsche, F. R., Agaimy, A., Hartmann, A., & Riener, M. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04091.x · Cited by 38
Szarvas, T., Dorp, F. V., Niedworok, C., Melchior‐Becker, A., Fischer, J. W., Singer, B. B., Reis, H., Bánkfalvi, Á., Schmid, K. W., Romics, I., et al. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11149.x · Cited by 37
Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes
Mentrikoski, M. J., Ma, L., Pryor, J. G., McMahon, L. A., Yang, Q., Spaulding, B. O., Scott, G., Wang, H. L., & Xu, H. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.128 · Cited by 34
An Immunohistochemical Panel to Distinguish Ovarian From Uterine Serous Papillary Carcinomas
Zhang, Y., Garcia-Buitrago, M. T., Koru‐Sengul, T., Schuman, S., & Ganjei‐Azar, P. (2013) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31826ddc4e · Cited by 34
Shi, J., Liu, H., Wang, H. L., Prichard, J. W., & Lin, F. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.06.010 · Cited by 34
Lin, C., Chen, S., Jeng, Y., Yeh, C.-C., Chou, H.-Y., Deng, Y., Chang, C., & Kuo, M. Y. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01019.x · Cited by 32
IMP3 expression in non–small cell lung cancer
Bellezza, G., Cavaliere, A., & Sidoni, A. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.03.019 · Cited by 30
Kim, K., & Cha, I. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1129-3 · Cited by 28
Fadare, O., Liang, S. X., Crispens, M. A., Jones, H. W., Khabele, D., Gwin, K., Zheng, W., Mohammed, K. S., Parkash, V., Hecht, J. L., et al. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.12.003 · Cited by 28
Vercellini, P., Cribiù, F. M., GOBBO, A. D., Carcangiu, M. L., Somigliana, E., & Bòsari, S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.02.002 · Cited by 27
Morimatsu, K., Aishima, S., Yamamoto, H., Hayashi, A., Nakata, K., Oda, Y., Shindo, K., Fujino, M., Tanaka, M., & Oda, Y. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.12.020 · Cited by 27
Up-Regulation of Imp3 Confers In Vivo Tumorigenicity on Murine Osteosarcoma Cells
Ueki, A., Shimizu, T., Masuda, K., Yamaguchi, S. I., Ishikawa, T., Sugihara, E., Onishi, N., Kuninaka, S., Miyoshi, K., Muto, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050621 · Cited by 26
Prognostic value of tissue and circulating levels of IMP3 in prostate cancer
Szarvas, T., Tschirdewahn, S., Niedworok, C., Kramer, G., Sevcenco, S., Reis, H., Shariat, S. F., Rubben, H., & Dorp, F. V. (2014) · International Journal of Cancer · doi:10.1002/ijc.28808 · Cited by 25
Chen, Y., Jeng, Y., Hsu, H., Lai, H., Lee, P., Lai, P., & Yuan, R. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.11.021 · Cited by 25
Chen, S., Jeng, Y., Chang, C., Chang, H., Huang, M., Juan, H., Hsu, C., Lee, H., Liao, Y., Lee, Y., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02100.x · Cited by 25
Hartmann, E., Beà, S., Navarro, A., Trapp, V., Campo, E., Ott, G., & Rosenwald, A. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.84 · Cited by 25
Git, A., Allison, R. J., Perdiguero, E., Nebreda, Á. R., Houliston, E., & Standart, N. (2009) · RNA · doi:10.1261/rna.1195709 · Cited by 24
Danialan, R., Assaad, M. W., Burghardt, J., Newcomb, P., Cartun, R. W., & Mandavilli, S. R. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.04.020 · Cited by 18
The Oncofetal Protein IMP3: A Novel Molecular Marker to Predict Aggressive Meningioma
Hao, S., Smith, T. W., Chu, P. G., Liu, Q., Ok, C. Y., Woda, B. A., Lü, D., Lin, P., Wang, S. A., Dresser, K., et al. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2009-0652-oar2 · Cited by 17
VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival
Davidson, B., Rosenfeld, Y. B.-Z., Holth, A., Hellesylt, E., Trope, C. G., Reich, R., & Yisraeli, J. K. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.03.005 · Cited by 15
Cited by
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huang, H., Weng, H., & Chen, J. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.02.004 · Cited by 1,226
High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer
Grosselin, K., Durand, A., Marsolier, J., Poitou, A., Marangoni, E., Nemati, F., Dahmani, A., Lameiras, S., Reyal, F., Frenoy, O., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0424-9 · Cited by 466
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner
Müller, S., Glaß, M., Singh, A. K., Haase, J., Bley, N., Fuchs, T., Lederer, M., Dahl, A., Huang, H., Chen, J., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1012 · Cited by 379
Self-citationEpigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis
Hanniford, D., Ulloa-Morales, A., Karz, A., Berzoti-Coelho, M. G., Moubarak, R. S., Sánchez-Sendra, B., Kloetgen, A., Davalos, V., Imig, J., Wu, P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.007 · Cited by 349
Degrauwe, N., Suvà, M.-L., Janiszewska, M., Riggi, N., & Stamenkovic, I. (2016) · Genes & Development · doi:10.1101/gad.287540.116 · Cited by 324
Metadata
- Authors
- Lederer, M., Bley, N., Schleifer, C., & Hüttelmaier, S.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 29
- Pages
- 3-12
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2091408887
- Cited by
- 287
- References
- 87
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.